The last time In Vivo spoke with 2020 Rising Leader Laura Soucek about Peptomyc S.L., the Barcelona-based biotech she co-founded and is CEO of, she was preparing to start a Phase I trial for the company’s lead Myc inhibitor, OMO-103. [A# IV124628]
At the time, the story was that she was pushing up against established dogma. Myc was undruggable, according to most...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?